Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds Vivasgenetics-dysmorphology-and-metabolism

Paeds Vivas · genetics-dysmorphology-and-metabolism

Tuberous sclerosis complex — branching viva

Branching viva on tuberous sclerosis complex: applying the 2012 consensus diagnostic criteria, explaining the hamartin-tuberin-Rheb-mTORC1 mechanism, building surveillance around SEGA and epilepsy, and offering everolimus for growing SEGA and refractory seizures.

branching clinical structured oral2 min readVerification in progress

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
On this page
Study tools

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
Outpatient clinic: a seven-month-old boy with clusters of flexor spasms, developmental regression, three hypomelanotic macules on Wood's lamp examination, and an EEG showing hypsarrhythmia. The examiner asks: what is the diagnosis and which criteria do you apply, what is the molecular basis, how would you explain the diagnosis and recurrence risk to the family, and what is the immediate and long-term management — then branches to a six-year-old with a growing subependymal giant cell astrocytoma abutting the foramen of Monro and asks how you would manage it, and finally to a fetus with an antenatally detected cardiac rhabdomyoma and asks how you would confirm and counsel.

Opening framework

My framework has four layers. First, the diagnosis — this baby with infantile spasms, hypomelanotic macules and hypsarrhythmia has tuberous sclerosis complex, which I confirm with the 2012 consensus criteria. Second, the mechanism — a loss-of-function variant in TSC1 or TSC2 that abolishes the hamartin-tuberin complex, the GTPase-activating protein that brakes Rheb and mTORC1. Third, the management — vigabatrin first-line for the spasms, then lifelong organ-by-organ surveillance. Fourth, the family — cascade testing and counselling on the 50 per cent autosomal-dominant recurrence risk. [1]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References6ShowHide
  1. [1]Henske EP, Jóźwiak S, Kingswood JC, et al. Tuberous sclerosis complex. Nat Rev Dis Primers, 2016.PMID 27226234
  2. [2]Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet, 2008.PMID 18722871
  3. [3]Northrup H, Krueger DA; International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Group. Pediatr Neurol, 2013.PMID 24053982
  4. [4]Krueger DA, Northrup H; International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Group. Pediatr Neurol, 2013.PMID 24053983
  5. [5]Franz DN, Belousova E, Sparagana S, et al. Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study. Lancet Oncol, 2014.PMID 25456370
  6. [6]French JA, Lawson JA, Yapici Z, et al. Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis complex (EXIST-3). Lancet, 2016.PMID 27613521
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousSyndromic craniosynostosis and craniofacial disorders — branching vivagenetics-dysmorphology-and-metabolismNextTurner syndrome — branching vivagenetics-dysmorphology-and-metabolism